AETHLON MEDIC.NEW DL-001

Research AETHLON MEDIC.NEW DL-001 (EJU) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerEJU
• ExchangeSTU
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyEUR
• Financial periodQ4 2025
• Net income-EUR 2.02M
• Free cash flow-EUR 1.88M

About AETHLON MEDIC.NEW DL-001

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Frequently asked questions

What does AETHLON MEDIC.NEW DL-001 do?

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States.